Pathology of moribund Socs1Iox/−LysM-cre and Socs1Iox/−Alb-cre/LysM-cre mice
. | Socs1Iox/−non-Tg . | Socs1Iox/−LysM-cre . | Socs1Iox/−Alb-cre/LysM-cre . |
|---|---|---|---|
| No. mice | 9 | 16 | 10 |
| Spleen, % mice with lesion | |||
| Enlargement | 0 | 63 | 100 |
| Reticuloendothelial cell hyperplasia | 0 | 75 | 100 |
| Lymphoid follicles | 100 | 81 | 90 |
| Germinal centers | 100 | 25 | 20 |
| Excess erythroid cells | 66 | 93 | 100 |
| Lymph node, % mice with lesion | |||
| Reticuloendothelial cell hyperplasia | 0 | 63 | 70 |
| Thymus, % mice with lesion | |||
| Atrophy of the cortex | 0 | 100 | 100 |
| BM, % mice with lesion | |||
| Granulocytic > mononuclear cells | 11 | 87 | 90 |
| Liver, % mice with lesion | |||
| Minor infiltration | 0 | 50 | 10 |
| Major infiltration | 0 | 50 | 90 |
| Hepatocyte damage | 0 | 25 | 70 |
| Pancreas, % mice with lesion | |||
| Infiltration | 0 | 50 | 50 |
| Lung, % mice with lesion | |||
| Macrophage/lymphocyte cuffing | 0 | 75 | 80 |
| Macrophage/lymphocyte foci | 0 | 50 | 70 |
| Pneumonia | 0 | 50 | 40 |
| Skeletal muscle, % mice with lesion | |||
| Infiltration | 0 | 50 | 30 |
| Gut, % mice with lesion | |||
| Infiltration | 0 | 60 | 40 |
| Skin, % mice with lesion | |||
| Epithelia hyperplasia | 11 | 19 | 20 |
| Body weight, g* | 21.6 ± 1.7 | 20.1 ± 1.6 | 20.4 ± 0.9 |
| Spleen weight, mg* | 95 ± 33 | 849 ± 405‡ | 860 ± 247† |
. | Socs1Iox/−non-Tg . | Socs1Iox/−LysM-cre . | Socs1Iox/−Alb-cre/LysM-cre . |
|---|---|---|---|
| No. mice | 9 | 16 | 10 |
| Spleen, % mice with lesion | |||
| Enlargement | 0 | 63 | 100 |
| Reticuloendothelial cell hyperplasia | 0 | 75 | 100 |
| Lymphoid follicles | 100 | 81 | 90 |
| Germinal centers | 100 | 25 | 20 |
| Excess erythroid cells | 66 | 93 | 100 |
| Lymph node, % mice with lesion | |||
| Reticuloendothelial cell hyperplasia | 0 | 63 | 70 |
| Thymus, % mice with lesion | |||
| Atrophy of the cortex | 0 | 100 | 100 |
| BM, % mice with lesion | |||
| Granulocytic > mononuclear cells | 11 | 87 | 90 |
| Liver, % mice with lesion | |||
| Minor infiltration | 0 | 50 | 10 |
| Major infiltration | 0 | 50 | 90 |
| Hepatocyte damage | 0 | 25 | 70 |
| Pancreas, % mice with lesion | |||
| Infiltration | 0 | 50 | 50 |
| Lung, % mice with lesion | |||
| Macrophage/lymphocyte cuffing | 0 | 75 | 80 |
| Macrophage/lymphocyte foci | 0 | 50 | 70 |
| Pneumonia | 0 | 50 | 40 |
| Skeletal muscle, % mice with lesion | |||
| Infiltration | 0 | 50 | 30 |
| Gut, % mice with lesion | |||
| Infiltration | 0 | 60 | 40 |
| Skin, % mice with lesion | |||
| Epithelia hyperplasia | 11 | 19 | 20 |
| Body weight, g* | 21.6 ± 1.7 | 20.1 ± 1.6 | 20.4 ± 0.9 |
| Spleen weight, mg* | 95 ± 33 | 849 ± 405‡ | 860 ± 247† |
*For body and spleen weights, 6 nontransgenic, 6 LysM-cre, and 2 Alb-cre/LysM-cre mice were analyzed. The means ± SD are shown. Statistical significance (Mann-Whitney test): †P < .05; ‡P < .001.